AstraZeneca

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. 

CEO
Pascal Soriot
CEOPascal Soriot
Employees
96,100
Employees96,100
Headquarters
Cambridge, Cambridgeshire
HeadquartersCambridge, Cambridgeshire
Founded
1913
Founded1913
Employees
96,100
Employees96,100

AZN Key Statistics

Market cap
242.25B
Market cap242.25B
Price-Earnings ratio
23.50
Price-Earnings ratio23.50
Dividend yield
1.68%
Dividend yield1.68%
Average volume
2.72M
Average volume2.72M
High today
$162.07
High today$162.07
Low today
$155.80
Low today$155.80
Open price
$160.76
Open price$160.76
Volume
2.41M
Volume2.41M
52 Week high
$212.71
52 Week high$212.71
52 Week low
$153.41
52 Week low$153.41

Stock Snapshot

The current AstraZeneca(AZN) stock price is $155.82, with a market capitalization of 242.25B. The stock trades at a price-to-earnings (P/E) ratio of 23.50 and offers a dividend yield of 1.68%.

As of 2026-10-13, AstraZeneca(AZN) stock has fluctuated between $155.80 and $162.07. The current price stands at $155.82, placing the stock +0.0% above today's low and -3.9% off the high.

The AstraZeneca(AZN)'s current trading volume is 2.41M, compared to an average daily volume of 2.72M.

In the last year, AstraZeneca(AZN) shares hit a 52-week high of $212.71 and a 52-week low of $153.41.

In the last year, AstraZeneca(AZN) shares hit a 52-week high of $212.71 and a 52-week low of $153.41.

AZN News

TipRanks 6h
AstraZeneca’s Pediatric Nexium Study Moves Toward Data Readout, Supporting Long-Term GI Franchise - TipRanks

...

AstraZeneca’s Pediatric Nexium Study Moves Toward Data Readout, Supporting Long-Term GI Franchise - TipRanks
TipRanks 13h
AstraZeneca upgraded to Buy from Sell at Nordea

Nordea double upgraded AstraZeneca (AZN) to Buy from Sell with a price target of SEK 1,900, up from SEK 1,650. The firm sees investor focus returning to the com...

TipRanks 5d
AstraZeneca’s Kazakhstan Breast Cancer Study: Real‑World Data With Quiet but Important Signals for AZN

AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. AstraZeneca is running a new real‑world study in Kazakhstan to track how doctors...

Analyst ratings

90%

of 10 ratings
Buy
90%
Hold
0%
Sell
10%

More AZN News

TipRanks 5d
AstraZeneca’s Liver Cancer Trial Completion: What It Means for AZN Investors

AstraZeneca ($~AZN) announced an update on their ongoing clinical study. AstraZeneca’s latest update covers a Phase III trial in liver cancer that tests whethe...

People also own

Based on the portfolios of people who own AZN. This list is generated using Robinhood data, and it’s not a recommendation.
Pfizer
Honeywell Aerospace
Dominion Energy
Southern
Procter & Gamble
RTX Corporation

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.